Pioneer Surgical just announced the first human use of nanOss Bioactive 3D. The procedures were perfomed by Dr. Nicholas Matagaras at Good Samaritan Hospital in Downers, Illinois. The product is a three-dimensional shaped biologic bone graft which utilizes proprietary nanocrystalline hydroxyapatite as well as a collagen-based biopolymer to promote bone growth in posterolateral spine. Dr. [...]
Archive for the Category ◊ Biologics ◊
The regenerative medicine folks at Histogenics Corporation are generating some excitement as they move forward with a new company and a new person at the helm. Histogenics has announced that it has acquired ProChon BioTech Ltd. in a stock-for-stock exchange. Leading the new management team will be President & CEO Patrick O’Donnell, formerly CEO of [...]
DUBLIN, May 17, 2011 /PRNewswire-FirstCall/ — Shire plc (LSE:SHP.l – News), the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire Advanced BioHealing, Inc. – Creation of a new strategic platform based on tissue regeneration using cell-based therapies complements Shire’s existing specialty focus and biologics manufacturing capability – Strong [...]
Orthopedic implant and surgical products maker Stryker Corp. said Monday it will buy rival Orthovita Inc. for about $304 million in cash. Orthovita’s products include Vitoss bone grafts and Cortoss bone augmentation material. It also sells Vitagel, which is designed to reduce bleeding. Stryker is offering $3.85 per share, a premium of 41 percent from [...]
Using injectable hollow, biodegradable nanofiber spheres as cell carriers is likely to repair knee cartilage more effectively than current methods, said US researchers in a paper published online in Nature Materials this week. Lead author Peter Ma, a professor at the University of Michigan (U-M) School of Dentistry, told the press they hope their method will [...]
Embattled ReGen Biologics Inc. files voluntary petitions for Chapter 11 bankruptcy protection and announces a $1 million private placement from one of its largest investors. ReGen Biologics Inc. (PINK:RGBO) filed for Chapter 11 bankruptcy protection with the U.S. Bankruptcy Court for the District of Delaware. The embattled maker of the Menaflex knee implant said in [...]
RALEIGH, N.C., March 8, 2011 /PRNewswire/ — Pioneer Surgical Technology today announces the market launch of their new portfolio of biologic products, designed to be used in extremities and pelvis. The new portfolio will be showcased during the 2011 American College of Foot and Ankle Surgeons (ACFAS) convention in Fort Lauderdale this week. Pioneer Surgical Technologys newest Biologics product, [...]
Launching and hoping for accurate target market hits…curasan AG and Stryker S.A., Montreux, Switzerland, have signed an agreement to sell and market bone replacement and regeneration materials for a variety of orthopedic indications. In summer 2011, Stryker anticipates launching the products in selected European countries to be potentially followed by further target markets. “Partnering with [...]
It’s got all of the bells and whistles of the research world…BioMimetic Therapeutics, Inc. has announced the initiation of enrollment in its multi-center, randomized, controlled, blinded study to assess the safety and clinical utility of Augment Rotator Cuff Graft for the repair of large rotator cuff tears. This pilot clinical trial will assess the Augment [...]
The RAVINE Lateral Access System was one of the new products announced at this year’s North American Spine Society (NASS) 2010 annual meeting. This is the first product introduced by the company for the far lateral market and also expands K2M’s focus on minimally invasive products. So what are the specs on RAVINE? Well it [...]




Recent Comments